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ABSTRACT
Objective Registries are a well-established mechanism
for obtaining high quality, disease-speciﬁc data, but are
often highly project-speciﬁc in their design,
implementation, and policies for data use. In contrast to
the conventional model of centralized data contribution,
warehousing, and control, we design a self-scaling
registry technology for collaborative data sharing, based
upon the widely adopted Integrating Biology & the
Bedside (i2b2) data warehousing framework and the
Shared Health Research Information Network (SHRINE)
peer-to-peer networking software.
Materials and methods Focusing our design around
creation of a scalable solution for collaboration within
multi-site disease registries, we leverage the i2b2 and
SHRINE open source software to create a modular,
ontology-based, federated infrastructure that provides
research investigators full ownership and access to their
contributed data while supporting permissioned yet
robust data sharing. We accomplish these objectives via
web services supporting peer-group overlays,
group-aware data aggregation, and administrative
functions.
Results The 56-site Childhood Arthritis & Rheumatology
Research Alliance (CARRA) Registry and 3-site Harvard
Inﬂammatory Bowel Diseases Longitudinal Data
Repository now utilize i2b2 self-scaling registry
technology (i2b2-SSR). This platform, extensible to
federation of multiple projects within and between
research networks, encompasses >6000 subjects at
sites throughout the USA.
Discussion We utilize the i2b2-SSR platform to
minimize technical barriers to collaboration while
enabling ﬁne-grained control over data sharing.
Conclusions The implementation of i2b2-SSR for the
multi-site, multi-stakeholder CARRA Registry has
established a digital infrastructure for community-driven
research data sharing in pediatric rheumatology in the
USA. We envision i2b2-SSR as a scalable, reusable
solution facilitating interdisciplinary research across
diseases.
OBJECTIVE
Registries are a well-established mechanism for
obtaining high quality, disease-speciﬁc data on
distinct cohorts of subjects with preselected
diseases, environmental exposures, and/or treat-
ments of interest.
1 We describe the development
and implementation of a self-scaling, interoperable
platform for collaborative data sharing based upon
the widely adopted Informatics for Integrating
Biology & the Bedside (i2b2) framework
2 and
report use of this i2b2 self-scaling registry tech-
nology (i2b2-SSR) for the 56-site Childhood
Arthritis & Rheumatism Research Alliance
(CARRA) Registry of pediatric rheumatic diseases
and Harvard Inﬂammatory Bowel Disease Longi-
tudinal Data Repository.
BACKGROUND AND SIGNIFICANCE
The potential of disease registries to collect high
quality data and support multi-center studies, com-
parative effectiveness research, and post-marketing
surveillance, has never been greater. Yet registry
effortsareoftenhighlyproject-speciﬁcintheirdesign,
implementation, and policies for data use.
Disease registries range from rare disease projects
(where no single center can ever produce sufﬁcient
numbers for study),
3 4 to single-investigator
studies,
56and to large, multi-site, national public
health efforts such as the $50+ million/year
Centers for Disease Control National Program of
Cancer Registries
7 and the National Cancer Insti-
tute’s Surveillance, Epidemiology, and End Results
Registry (SEER) program. The landscape is one of
isolated, autonomous, and often overlapping clin-
ical data repositories with dissimilar data schemas.
8
Historically, registries have conformed to a model
of centralized data contribution, warehousing, and
control.
9 Further, considerations of authorship and
academic credit
10 11 may deter principal investiga-
tors from more widely sharing their datasets,
1 12
producing a chilling effect on multicenter study.
The Institute of Medicine and others have
persuasively argued that the development of less
compartmentalized, multi-stakeholder strategies
for data sharing is critical to the conduct of relevant
and innovative clinical research analyses.
2 13e16
Nonetheless, only a relatively few successful efforts
for widespread, registry-based data sharing have
been accomplished in the USA to date and no
infrastructure has yet emerged as a recognized
standard. Instead, registry data collection, ware-
housing, and use traditionally follow a self-
contained model that, by design, offers neither
modularity nor scalability: data are typically
collected for registry-limited use cases, data
elements may not be recorded or normalized to
externally meaningful standards, and data
providers usually surrender their data to a centrally
administered repository to which they then have
limited access. While serving individual study goals,
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25 June 2012such constraints adversely impact the reusability, cross-disci-
plinary generalizability, and return on investment of registries to
the larger research enterprise.
Firmly grounded on the use case of a rare disease registrydthe
multi-site CARRA Registry of pediatric rheumatic diseasesdwe
address the desiderata of a national scale infrastructure for
chronic disease registries in a real world deployment of
a modular, reusable, and readily extensible research data storage
and sharing framework. Our efforts are based on two highly
diffusible, open source technologies: the i2b2 informatics
framework
3 4 17 18 and the Shared Health Research Information
Network (SHRINE).
5 6 18 These platforms provide a well-tested
foundation for cross-institutional data aggregation within the
health information sector and have been used for multi-munic-
ipality syndromic biosurveillance (AEGIS),
7 19 cohort identiﬁ-
cation across the Harvard-afﬁliated hospitals (SHRINE),
8 18 and
multi-institutional neuroscientiﬁc research (Biomedical Infor-
matics Research Network (BIRN)).
9 20 21
MATERIALS AND METHODS
In 2009, the CARRAda consortium comprising pediatric rheu-
matology clinical research centers in North Americadreceived
critical infrastructure funding from the National Institute of
Arthritis and Musculoskeletal and Skin Diseases (NIAMS,
RC2AR058934) to establish the longitudinal CARRA Registry
network (CARRAnet).
The i2b2-based self-scaling registry platform (i2b2-SSR)
developed for this purpose allows individual investigators and
institutions to join a secure research data network by contrib-
uting a unique dataset and working with others to create larger,
collaborative datasets that may be shared with the network as
a whole or within speciﬁc subsets of sites and investigators. An
administrative and auditing layer provides control of user
permissions along with logging of user queries, assuring
compliance with Institutional Review Board (IRB) and other
regulatory protections for subjects, as well as allowing moni-
toring of data usage according to the research network’s guide-
lines. A scenario illustrates the functionality:
Part 1. Dr Susan Smith, a clinician-researcher, is principal
investigator (PI) of a small, multi-site trial demonstrating
efﬁcacy of the new biologic therapy ‘BioX’ for childhood-onset
arthritis. Following regulatory approval of BioX therapy, she
wants to extend her study to address the long-term safety of
BioX and to engage more sites. Dr Smith discusses this with Dr
Robert Rogers, who is wrapping up a similar post-marketing
study for the earlier generation ‘BioA’ therapy.
Dr Rogers expresses concerns about the difﬁculties that Dr
Smith will encounter in recruiting and retaining enough sites
and subjects for another independent, long-term post-marketing
surveillance study. Dr Smith, however, explains that rather than
undertake another self-contained study, she intends to join her
current study to the new, 60-site i2b2-SSR consolidated registry,
which is already collecting 75% of the data elements she needs
for the new study. She proposes a further collaboration in which
Dr Rogers would be able to share his study’s multi-site data by
establishing his own i2b2-SSR repository. She explains to Dr
Rogersdwho is somewhat reluctant to share data widely prior
to reaching his study’s ﬁnal endpointdthat he may ﬁrst elect
a limited collaboration with Dr Smith and make future decisions
about data sharing on a study-by-study basis.
To join the i2b2-SSR network, Dr Smith uploads each
participating site’s data from her existing BioX trial to i2b2-
SSR (one data warehouse per site). As study PI, Dr Smith is able
to query all of the study sites as one virtual repository, and each
site is also able to view the data it has contributed to the
study. As an incentive for existing BioX study sites to continue
their participation in the next, post-marketing surveillance
phase, and to encourage new participation from additional
sites, Dr Smith decides to grant appropriate permissions for any
study site investigator to execute limited queries (counts
of patients only, no subject-speciﬁc results) across all sites
in this new BioX study.
Dr Rogers, now comfortable with sharing his BioA study’s
extensive data in a permissioned fashion exclusively with Dr
Smith, uploads the BioA data to his own i2b2-SSR instance and
provides Dr Smith with ‘counts-only’ query permission. Dr
Smith provides Dr Rogers with reciprocal permissions, and they
are now able to query summary data from both of their
studies as a combined BioA/BioX virtual database.
Part 2. Dr Amy Allen, a junior clinician-researcher, believes that
patients taking certain biologics, including BioX, improve when
taking VitaG supplements. As a participating investigator in Dr
Smith’s BioX post-marketing surveillance study, she logs onto
i2b2-SSR and deﬁnes a query for patients on BioX who are also
taking vitamin supplements. Dr Allen discovers there are 80
subjects who might be candidates for testing, but wonders if
there are too few control subjects in Dr Smith’s cohort for her
planned analyses to be meaningful. On contacting Dr Smith to
discuss obtaining full, subject-level access to the BioX dataset,
Dr Smith conﬁrms an inadequate control population in the BioX
cohort alone, but executes a query on the i2b2-SSR multi-site
BioA/BioX database, returning aggregate counts that conﬁrm
adequate numbers for Dr Allen’s research.
Dr Smith suggests that they both contact Dr Rogers with
a request that Dr Allen be allowed to run a set of speciﬁc,
subject-level queries on the BioA/BioX repository. The three
researchers agree to collaborate and both Dr Rogers and Dr
Smith grant Dr Allen permission to execute subject-level
queries within the scope of her research on their
respective datasets over a 2-month period.
This scenario illustrates our objectives for a modular, collab-
orative, self-scaling registry providing minimal barriers to
participation. We have focused our i2b2-SSR development
efforts around ﬁve design principles:
1. Provide data contributors with full ownership of and access
to their own data
2. Minimize barriers for data owners to collaboratively
contribute their data to new or existing datasets
3. Support a tiered sharing model which provides a granular,
permissioned, and audit-capable data sharing framework
4. Enable near real-time access to data, supporting a virtuous
cycle in which immediate data access promotes further data
contribution and collaboration
5. Encourage ongoing incorporation of outside datasets from
multiple sources.
We build on two core open-source technologies in current use:
(1) SHRINE, a peer-to-peer network designed for health infor-
matics allowing construction of permissioned, well-deﬁned data
interchange topologies between data repositories
10 11 18; and (2)
the Informatics for Integrating Biology & the Bedside (i2b2)
framework, a data warehousing and analytic platform that has
been put into use at more than 60 medical centers, encom-
passing health data on an estimated 45 million subjects world-
wide, and which is readily scalable via SHRINE.
2
The i2b2-SSR system supports the following administrator
actions:
< Establishment of a trust relationship between a data contrib-
utor (i2b2-SSR node) and a data aggregator (i2b2-SSR
Research and applications
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certiﬁcates distributed by mutually trusted certiﬁcate author-
ities (CAs)
< Creation and modiﬁcation of peer groups for collaboration,
wherein one or more data contributors agree(s) to allow
query access to a dataset
< Mapping of ﬁne-grained data query privileges to an i2b2-SSR
end user, including designation of
– User membership in one or more peer groups
– One or more optional ‘My Home Node(s)’ for each user
– User data access authorization, wherein queries will return
either
– Simple counts of subjects fulﬁlling a query, or
– Detailed data resulting from the query, as well as counts
of subjects
– Data origin to display to a user, where returned counts and/
or detailed data will be tagged with the identity of the data
contributor in one of three permutations
– Only peer group is identiﬁed (ie, no unique origin
information is returned), or
– Only ‘My Home Node’ data are identiﬁed (ie, ‘me’ versus
all others in peer group), or
– All data are fully identiﬁed by data origin
< Display and monitoring of network health, including nodes
not responding to queries
< Generation of audit reports of user activity and queries
submitted.
For the end-user, the i2b2-SSR system supports the following
actions:
< Display and selection of peer groups and data privileges for
which a user is authorized
< Ontology-based display of data elements and construction of
complex queries via web interface
< History of queries performed
< Generation and display of aggregated query results, including
a pluggable reporting system which supports BIRT
22 and R-
based
23 24 data visualizations and exports.
Regulatory oversight of data use, most often in the form of
IRB review, is a pre-condition for the release and sharing of
health research data in the USA and elsewhere. Especially for
multi-stakeholder collaborations where distinct data disclosure
policies apply to different data contributors and consumers over
time, a high cost-complexity penalty may exist which burdens
and discourages productive information sharing. Cognizant of
these concerns, we directly incorporate mechanisms for
addressing third-party oversight of data sharing in our design. In
addition to support for logging and auditing data access by users,
the gatekeeper roles of regulatory agents are instantiated as
digital certiﬁcate policies within i2b2-SSR, that is, an IRB is
analogous to a certiﬁcate authority (CA). In this model, a data
contributor must secure a digitally signed, time-limited certiﬁ-
cate from a CA that is trusted by the data aggregator. Recipro-
cally, a data aggregator must present a certiﬁcate validated by
a CA that the data contributor trusts, thereby establishing
a bidirectional relationship.
Components of the system: access to data
The i2b2-SSR architecture provides access to data via the
components depicted in ﬁgure 1 and described below.
End user (A)
The end user, typically a research investigator, accesses the
registry through a web-based query interface. Following secure
log in, the user encounters a graphical query builder interface in
which registry-speciﬁc ontologies may be browsed; search terms
may be dragged and dropped to construct queries to deﬁne
subject cohorts of potential interest. Selected cohorts are
returned as patient sets, for which choices of pre-deﬁned
summary reports and visualizations may be generated in real
time (ﬁgure 2). In this way, end users may iteratively reﬁne their
searches and are able, with appropriate authorizations, to
download the resulting datasets for further analyses.
Webserver (B)
The webserver proxies all federated queries from the end user. It
is a server-side component designed as a replacement to the
standard SHRINE web client. The webserver assembles i2b2
query panels from the end user-deﬁned queries and employs
Figure 1 The i2b2-SSR architecture.
The diagram illustrates the interaction
of i2b2-SSR core web services C and D,
which are customized, i2b2-SSR ‘drop-
in’ replacements for the standard
SHRINE Broadcaster/Aggregator and
i2b2 Project Manager Cell, respectively.
In coordination with the i2b2-SSR
Overlay Service (E), these modules
support introduction of peer-group
overlays for sharing of multiple datasets
(I) using standard i2b2 nodes and
SHRINE adapters (detail H). The
authorized end-user (A) constructs
a query based on shared ontologies that
are pre-deﬁned for the shared datasets.
The Shared Ontology Service (F) may
employ a standard i2b2 Ontology cell;
alternatively, we provide an i2b2
Ontology module with the i2b2-SSR
distribution that implements memory-
based caching with ontology term
search and autocomplete capabilities.
Research and applications
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reporting interface for providing summary data, data visualiza-
tions, analyses incorporating missing data, and exports is
implemented using a business-intelligence layer (BIRT reports
and/or R).
Broadcaster/Aggregator (C)
The Broadcaster/Aggregator is the i2b2-SSR component
responsible for receiving end user i2b2 query panels, broad-
casting them to various groupings of nodes that are sharing data,
and then aggregating the results received. The Broadcaster/
Aggregator uses XML digital signatures to encrypt and validate
all incoming and outgoing messages. Using digitally signed
certiﬁcates for coordinating trust relationships, the Broadcaster/
Aggregator component veriﬁes that data contributor nodes are
trusted sources.
Authorization module (D)
The Authorization (Auth) module is a customized i2b2-SSR
service that exposes an i2b2 Project Management cell interface
to the Webserver and Broadcaster/Aggregator. It acts as the
central, trusted authentication provider for the i2b2-SSR plat-
form by issuing signed tokens that the Broadcaster/Aggregator
subsequently validates. In addition, the Auth service functions
as an identity provider or may proxy to an outside identity
service such as Lightweight Directory Access Protocol or
Microsoft Active Directory. In either case, once a user has been
authenticated and properly logged-in, a session token is vended
by the Auth service. This token encodes the combinations of
query and data viewing privileges for which the user has been
authorized, thereby determining which datasets a user can
access and controlling the data granularity exposed.
Overlay Service (E)
The Overlay Service (OLS) is the i2b2-SSR directory service that
is responsible for maintaining the distinct federated, collabora-
tive topologies supported for a speciﬁc i2b2-SSR network. It uses
a simple RESTful web service application programming interface
(API) that allows users with administrative privileges to add or
remove i2b2 data contributor nodes and deﬁne new peer
groupings. The Broadcaster/Aggregator references these OLS
groupings to determine which set of nodes to route a particular
query broadcast to.
Shared Ontology service (F)
The Shared Ontology service provides web service access to
hierarchical vocabularies that describe i2b2 data elements and
provide term mappings for i2b2 query panels. This component
functions identically to the standard i2b2 Ontology Cell for
query panels, with the additional external policy requirement
that at least one common vocabulary exists and is mapped at all
data contributor nodes. In practice, as part of the Shared
Ontology model, we additionally provide the requisite i2b2
concept dimension rows as a Shared Ontology service public
table; however, these additional term mappings may be equiv-
alently implemented at the SHRINE adapter translation layer.
25
We also utilize a new, streamlined Shared Ontology module that
incorporates Apache Lucene search capabilities.
i2b2 federated Data Warehouses (G)
The collection of site-speciﬁc i2b2 Data Warehouses deﬁnes the
pool of potential data contributors to an i2b2-SSR network. For
production use in CARRAnet, a hosted i2b2 Virtual Machine
(i2b2VM) server farm has been established, within which each
collaborating data contributor is provisioned a dedicated
i2b2VM. Each site investigator is provided with full access to
their contributed data, with capability for the hosting and
sharing of multiple datasets across the entire registry network or
only within speciﬁed subgroups of collaborating investigators.
i2b2 instance details (H)
i2b2 instances deployed within i2b2-SSR consist of a combina-
tion of three standard SHRINE and i2b2 components: a SHRINE
adapter, an i2b2 Data Repository (also called the Clinical
Research Chart, or CRC) cell, and a Local Authorization module
(i2b2 Project Management cell). The SHRINE adapter receives
query panels conveyed within SHRINE requests from a trusted
Broadcaster/Aggregator and provides bidirectional translation
Figure 2 End user query interface.
The Site Investigator dashboard view is
shown, illustrating a sample
visualization of summary statistics for
site ‘ABC’ versus the entire CARRAnet
registry.
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mappings. The CRC stores data in a set of star-schema data
marts that comprises a local i2b2 data warehouse and interacts
with the Local Authorization module to expose an ontology-
aware query interface.
Shared datasets (I)
A single i2b2 instance may host multiple datasets. One dataset
may be federated with many other datasets within and across
i2b2 data warehouses that share common data ontologies. In
this way, large, interrelated datasets may be added or removed
incrementally in a self-scaling, modular fashion.
Components of the system: addition of network nodes
The self-scaling design of i2b2-SSR the enables addition of
network nodes via the components depicted in ﬁgure 3 and
described below.
Network Administrative User (J)
The Administrative User interface offers system management
capabilities for i2b2-SSR. It enables the network operator to
manage users, user permissions, Overlay Service peer groups, and
trust relationships and provides a dashboard to monitor the
overall health of the network.
i2b2 Data Contributor Administrative User (K)
Local i2b2 data repository administrative users enable their i2b2
instance to trust one or more Broadcaster/Aggregators via
conﬁguration of i2b2 and one or more local SHRINE adapters.
This enables end users hosting their own i2b2 instances to
ﬂexibly join i2b2-SSR data sharing networks ad hoc. Trust
relationships between an i2b2 instance data contributor and the
network are established via digital certiﬁcate exchange, typically
using a mutually trusted CA.
Certiﬁcate authority (L)
Our design accommodates use of one or more CAs to establish
mutual trust relationships and provide gatekeeper functionality
for data sharing within i2b2-SSR networks. A trusted third
party, such as an IRB or other institutional regulatory body, may
provide signed digital certiﬁcates via the CA; these are used by
the Broadcaster/Aggregator and local SHRINE adapter to
validate requests and securely encode responses exchanged
between components. Certiﬁcates distributed by CAs may
incorporate temporal constraints (eg, certiﬁcate expirations) and
also support certiﬁcate revocation policies speciﬁed by a data
sharing authority, such as an IRB.
Codebase
The i2b2-SSR code is available as open source software, licensed
under LGPL version 3 for i2b2-SSR components; constituent
components and dependencies are available under their respec-
tive open source licenses (repository and links at https://open.
med.harvard.edu/display/CARRANET). The Webserver package
is available from Cincinnati Children’s Hospital Medical Center
at https://bmi.cchmc.org/svn/i2b2/i2b2/public/.
RESULTS
As of February 2012, the CARRA Registry network comprised
56 actively recruiting sites with 237 investigators and over 6000
subjects enrolled, including data on more than 11000 registry
visits gathered since activation of the ﬁrst site in May 2010; this
represents the largest pediatric rheumatic diseases study cohort
in the USA to date and one of the largest worldwide.
26 The i2b2-
SSR platform provides secure, granularly permissioned, real-time
access to registry data for CARRAnet investigators and has been
adopted as the primary mechanism for return of results for the
pediatric rheumatology research community. Data sharing is
governed by well-deﬁned policies
27 intended to facilitate access
to data while fostering collaborative research in areas of scien-
tiﬁc priority and inclusion of early stage investigators. The
dataset continues to grow as researchers enter information daily,
with a current target enrollment of 10000 subjects at 60 sites
and regular longitudinal follow-up. Table 1 and ﬁgure 4 provide
a brief cross-sectional overview of the characteristics of registry
subjects at initial enrollment visit, obtained via i2b2-SSR feder-
ated query across all sites.
Figure 3 Self-scaling
architecturedadding new sites
(network nodes) and/or studies to an
i2b2-SSR network. With appropriate
approvals, a Site Administrator (K)
conﬁgures the local SHRINE adapter to
communicate with a particular registry
Broadcaster/Aggregator endpoint (C)
and installs a digital certiﬁcate
distributed by a certiﬁcate authority (L)
that is mutually trusted by the site and
the i2b2-SSR Network Administrator
(J).
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platform of choice for US investigators to initiate new and
enhanced clinical research studies in this population. As of mid-
2012, enhanced datasets from ﬁve newly funded disease-speciﬁc
efforts studying the comparative effectiveness of various
Consensus Treatment Plans
28 in pediatric rheumatic diseases
(pediatric systemic lupus erythematosus,
29 juvenile dermato-
myositis,
30 31 systemic-onset and polyarticular juvenile idio-
pathic arthritis,
32 33 localized scleroderma
34) will be incorporated
into the CARRAnet platform, with multiple additional efforts
actively planned, including biospecimen collection for trans-
lational research applications. In addition, with the anticipated
introduction of a publiceprivate partnership for pharmaceutical
post-marketing surveillance into CARRAnet,
4 the i2b2-SSR
infrastructure will provide a critical conduit for managing
permissioned access by researchers to a dual, research and
regulatory use dataset.
While initially deployed for within-network data sharing, the
i2b2-SSR platform is equally extensible to interdisciplinary
collaboration and data sharing. For certain crosscutting clinical
questions, such as general studies in autoimmunity or determi-
nation of uncommon but serious adverse event signals of
medications in pediatric patients, it is highly advantageous to
combine data from disparate sources. This may involve federa-
tion of data from different studies or projects housed within
a single node (intra-institutional), federation across different
studies housed within nodes of different networks (inter-insti-
tutional), or even federation of queries between collections of
distinct networks (trans-institutional). Within the context of an
ontology-based data warehouse framework such as i2b2,
extended topologies for federated queries are readily constructed
by aligning local ontologies to external, standardized vocabu-
laries such as SNOMED-CT and MedDRA. For example, Chil-
dren’s Hospital Boston is a contributing site for two
multi-center registry studies housed in separate i2b2-SSR nodes
and networks: the Harvard Inﬂammatory Bowel Diseases
Longitudinal Repository and the CARRA Registry. With
appropriate investigator and regulatory approvals, combined
federation between the two local registry nodes can be accom-
plished via straightforward changes to i2b2-SSR peer-group
conﬁguration by network administrators. Likewise, with
appropriate registry authorizations and existence of a shared,
trans-network ontology, data federation between all sites of
both registries becomes readily feasible.
DISCUSSION
Broadly federating and aggregating clinical research data is
a valuable capability pursued through a range of technological
strategies by a number of projects, including the cancer Biomed-
ical Informatics Grid (caBIG) caGrid platform
35 (which supports
a Uniﬁed Modeling Language (UML) based, federated network
architecture), the Mini-Sentinel Initiative,
36 37 the National
Database for Autism Research (NDAR)
38 and others,
39 40 including
efforts under active development such as Query Health.
41 Beyond
purely technical considerations, however, there exist consider-
able operational complexitiesdsocietal, organizational, and
economicdthat must be simultaneously addressed in order to
successfully bridge barriers to widespread data sharing in the
healthcare enterprise.
42e45
We believe that our two-tiered approach of (1) fostering grass-
roots efforts for data sharing by allowing participating investi-
gators full control of their contributed data while enabling them
to ﬂexibly join, or depart, data sharing networks in a dynamic,
ad hoc fashion with ﬁne-grained, transparent data access
permissions, and (2) leveraging the large, established, open
source infrastructure and installed base of i2b2-based data
warehousing, is an attractive recipe for fostering multi-func-
tional use of disease registries, enabling substantially greater
economies of scale and resources than the traditional, central-
ized, data silo approaches of the past century.
Federated queries over distributed i2b2 networks imply their
own set of unique challenges, for example, proper accounting for
same-patient data (when such facts are present in multiple
nodes), imputation of missing data points when queries return
null results, and the challenges of aggregating similar data
referred to using different ontologies. The i2b2-SSR peer group-
based trust and shared ontology approach provides a robust
framework for addressing such complexities. The capability to
implement heuristics on privileged, fact-level data while
exposing only select, computed views of federated information
Table 1 Diagnosis at baseline visit, Childhood Arthritis &
Rheumatology Research Alliance (CARRA) registry population (as of
February 2012)
Diagnosis N (%)
Juvenile idiopathic arthritis 4510 (72%)
Pediatric systemic lupus erythematosus 618 (10%)
Juvenile dermatomyositis 433 (7%)
Localized scleroderma 236 (4%)
Juvenile primary ﬁbromyalgia 122 (2%)
Vasculitis 117 (2%)
Mixed connective tissue disease 112 (2%)
Sarcoidosis 38 (1%)
Systemic sclerosis 36 (1%)
Figure 4 CARRA Registry, selected
demographics (as of February 2012,
data from 53 sites), see also table 1. (A)
Distribution of subject enrollment by
site. The majority of registry subjects
(3647 out of 6175 total subjects
enrolled, or w60%) are found at sites
enrolling <200 subjects (N¼44 sites),
reﬂecting the broad collaboration
needed within this research community
to achieve sufﬁcient populations to
conduct signiﬁcant research
investigations; (B) age at onset of
disease symptoms by disease
diagnosis. Upper age distribution is right-censored due to pediatric-onset inclusion criteria.
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challenges, thereby realizing the beneﬁts of centralized data
warehousing within a distributed, self-scaling system. Moreover,
incentivizing the growth of networks using shared ontologies
supports a much needed community-based, rather than data
silo, approach to the clinical research enterprise.
CONCLUSION
Building upon prior successful efforts at clinical data federation
using the i2b2 and SHRINE open source platforms,
2 17e19 46 we
have assembled a lightweight, reusable, peer-to-peer chronic
disease registry framework that promotes investigator partici-
pation through robust mechanisms for local control over data
ownership and sharing. The implementation of this framework
for the multi-site, multi-stakeholder CARRA Registry has
established a digital infrastructure for community-driven
research data sharing in pediatric rheumatology in the USA. The
future success of this technology will be measured by its real-
world application to fostering new collaborations in compara-
tive effectiveness and translational research within the network,
as well as by its value as a model for fostering grass-roots efforts
for data sharing in other investigator networks.
Our next steps for development of the i2b2-SSR infrastructure
will focus upon use of registry data as a core, gold-standard
reference by which to effectively leverage more voluminous
‘ambient’ health information, particularly patient-speciﬁc
information from electronic health records and patient-reported
outcomes. To accomplish this, we envision a self-scaling registry
paradigm that encompasses secure data federation across
multiple systems capable of patient-level linkage: i2b2-based
registries, electronic health record warehouses, and patient-
centric data systems (eg, personally controlled health record
systems for direct patient report). In this way, i2b2-SSR will not
only serve as infrastructure for data sharing, but will also fulﬁll
the need for an incremental, highly scalable, and reusable solu-
tion to conduct interdisciplinary research across diseases.
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